- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06756646
Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD
Exploring the Effects of Aerobic Exercise Combined With Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Kun-Ling Tsai, Ph.D.
- Numero di telefono: 5078 886-6-2353535
- Email: kunlingtsai@mail.ncku.edu.tw
Backup dei contatti dello studio
- Nome: Yu-Ting Huang, M.S.
- Numero di telefono: 5078 886-6-2353535
- Email: t66061053@pt.ncku.edu.tw
Luoghi di studio
-
-
Taiwan
-
Tainan, Taiwan, Taiwan, 701
- Reclutamento
- National Cheng Kung University Hostipal
-
Contatto:
- Kun-Ling Tsai, PhD
- Numero di telefono: 6219 062353535
- Email: kunlingtsai@mail.ncku.edu.tw
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- COPD classified as levels 2-4.
- Stable condition without worsening in the past three months.
- No participation in any rehabilitation program within the past six months.
- Ability to understand and follow verbal commands and cooperate with an exercise training program.
Exclusion Criteria:
- Unconscious or unable to cooperate with the evaluator.
- Hospitalization due to acute illness within the past three months.
- Severe joint diseases or history of lower limb surgery.
- Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
- Dependence on oxygen supply.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Usual care group
The Usual care group will receive COPD and exercise-related education. |
The participants will be provided by educational program about COPD self-care and home-based exercise approach. |
|
Sperimentale: Aerobic exercise group-cycling
The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months. |
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period. |
|
Sperimentale: BFR group-cycling + BFR
The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months. |
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Oxygen consumption (VO2)
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Oxygen consumption examined by cardiopulmonary exercise test |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Functional capacity
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Functional capacity examined by 6MWT |
Change from baseline (0 week) to follow up (20 weeks)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Heart Rate Variability
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Heart Rate Variability examined by autonomic nervous system |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Pulmonary function test
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Maximum respiratory pressure
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Maximum respiratory pressure examined by pressure meter |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-I)
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Quality of life score examined by mMRC Questionnaire. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-II)
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
COPD Assessment Test (CAT) questionaire |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-III)
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
St George's Respiratory Questionnaire (SGRQ) |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Diaphragm capacity
Lasso di tempo: Change from baseline (0 week) to follow up (20 weeks)
|
Diaphragm capacity examined by diaphragmatic ultrasound |
Change from baseline (0 week) to follow up (20 weeks)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Kun-Ling Tsai, Ph.D., Department of Physical Therapy, National Cheng Kung University
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- B-ER-113-298
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD sharing plan will be decided after summarized data being published.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .